Free Account Opening + AMC Free Demat
Loading...

Gland Pharma IPO vs Mrs. Bectors Food IPO

Comparision between Gland Pharma IPO and Mrs. Bectors Food IPO.

IPO Details

Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mrs. Bectors Food IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Mrs. Bectors Food IPO is up to ₹540.54 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Mrs. Bectors Food IPO is ₹288.00 per share.

  Gland Pharma IPO Mrs. Bectors Food IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹1,490.00 per share ₹286.00 per share
Issue Price (Upper) ₹1,500.00 per share ₹288.00 per share
Issue Price (Final) ₹1,500.00 per share ₹288.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 10 shares 50 shares
Fresh Issue Size 83,33,333 shares
Fresh Issue Size (Amount) up to ₹1,250.00 Cr up to ₹40.54 Cr
OFS Issue Size 3,48,63,635 shares
OFS Issue Size (Amount) up to ₹5,229.55 Cr up to ₹500.00 Cr
Issue Size Total 4,31,96,968 shares
Issue Size Total (Amount) up to ₹6,479.55 Cr up to ₹540.54 Cr

IPO Timetable

Gland Pharma IPO opens on Nov 09, 2020, while Mrs. Bectors Food IPO opens on Dec 15, 2020. The closing date of Gland Pharma IPO and Mrs. Bectors Food IPO is Nov 11, 2020, and Dec 17, 2020, respectively.

  Gland Pharma IPO Mrs. Bectors Food IPO
Anchor Bid Date
Issue Open Nov 09, 2020 Dec 15, 2020
Issue Close Nov 11, 2020 Dec 17, 2020
Basis Of Allotment (Tentative) Nov 17, 2020 Dec 22, 2020
Initiation of Refunds (Tentative) Nov 18, 2020 Dec 23, 2020
Credit of Share (Tentative) Nov 19, 2020 Dec 23, 2020
Listing date (Tentative) Nov 20, 2020 Dec 24, 2020
Anchor Lockin End date 1 Dec 17, 2020 Jan 21, 2021
Anchor Lockin End date 2 Feb 15, 2021 Mar 22, 2021

Financials

Gland Pharma IPO P/E ratio is , as compared to Mrs. Bectors Food IPO P/E ratio of .

  Gland Pharma IPO Mrs. Bectors Food IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-Sep-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 6,087.26 5,657.15 5,770.44 5,110.59
Total Revenue 4,385.55 7,649.76 7,860.29 6,957.55
Profit After Tax 388.83 304.03 331.50 358.93
Promoter Shareholding (Pre-Issue) 74% 52.45%
Promoter Shareholding (Post-Issue) 58% 51%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in Mrs. Bectors Food IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 37,76,502 shares in Mrs. Bectors Food IPO.

  Gland Pharma IPO Mrs. Bectors Food IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,39,394 shares 37,76,502 shares
NII 64,79,546 shares 28,32,378 shares
RII 1,51,18,939 shares 66,08,881 shares
Employee 0 shares 18,450 shares
Others
Total 3,02,37,879 shares 1,32,36,211 shares

Bids Received (Subscription)

Gland Pharma IPO subscribed 2.06x in total, whereas Mrs. Bectors Food IPO subscribed 198.02x.

  Gland Pharma IPO Mrs. Bectors Food IPO
QIB (times) 6.40x 176.85x
NII (times) 0.51x 620.86x
Big NII (times)
Small NII (times)
RII (times) 0.24x 29.33x
Employee (times) 45.46x
Other (times)
Total (times) 2.06x 198.02x

Comments

Add a public comment...